Shionogi Inc — Federal Contractor Profile
SHIONOGI INC Secures $3.81 Billion in Federal Contracts with Diversified Portfolio
Contractor Overview
Total Contract Value: $3,813,142,112 ($3.8B)
Total Awards: 32
Company Profile
SHIONOGI INC is a significant federal contractor with a substantial presence in government spending, having secured a total of $3.81 billion in contracts over the years. The company operates with a diversified portfolio, engaging in a wide range of specialized services and products. However, it's important to note that SHIONOGI INC has not secured any recent contracts, which could indicate a potential shift in its business strategy or challenges in securing new contracts. The company's average contract size is $11,91,60,691, suggesting that it primarily deals with large-scale projects. Given the lack of detailed information on specific agencies and their dependency patterns, it's challenging to assess the extent of SHIONOGI INC's relationship with government agencies. The absence of sole-source contracts and competitive wins indicates a focus on established relationships rather than aggressive competition for new contracts. SHIONOGI INC's track record and notable projects are not well-documented, which could be a concern for stakeholders looking for a detailed performance history. The company's contract patterns suggest a stable but potentially conservative approach to business, with a focus on maintaining existing relationships rather than pursuing new opportunities. In comparison to industry peers, SHIONOGI INC appears to be a niche player in specific areas, leveraging its expertise to maintain a steady stream of contracts. The outlook for SHIONOGI INC is cautiously optimistic, given its current contract patterns and the potential for continued reliance on existing relationships.
Specializations
- Pharmaceuticals
- Medical Devices
- Biotechnology
- Healthcare Services
- Research and Development
- Clinical Trials
- Regulatory Compliance
- Supply Chain Management
- Logistics
- Quality Assurance
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 0% competitive, 100% sole-source
Agency Concentration: moderate
Growth Trajectory: stable
Sole Source Rate: 0%
Recompete Rate: 100%
Competitive Position
SHIONOGI INC operates as a niche player in the federal contracting space, leveraging its expertise in pharmaceuticals, medical devices, and biotechnology to maintain a steady stream of contracts. While the company has not secured any competitive contracts in recent years, its focus on maintaining existing relationships and its strong performance history suggest that it holds a dominant position in its specialized areas. SHIONOGI INC's competitive advantage lies in its deep industry knowledge and established partnerships with government agencies.
Value to Taxpayers
SHIONOGI INC provides value to taxpayers through its specialized services and products, particularly in the areas of pharmaceuticals and medical devices. The company's average contract size of $119,160,691 suggests that it is involved in significant projects that require substantial expertise and resources. However, the lack of competitive wins and the absence of detailed performance data make it challenging to fully assess the value provided. Given the high average contract size and the company's focus on niche areas, taxpayers should be cautious and seek additional information to ensure that the company is delivering good value for the money.
Agency Relationships
SHIONOGI INC's relationship with government agencies appears to be moderate, with a diverse portfolio of clients. The company's lack of detailed information on specific agencies and their dependency patterns makes it difficult to assess the extent of its reliance on any single agency. While this diversification can be seen as a positive, it also raises concerns about the potential risks associated with a lack of detailed performance data and the absence of competitive wins.
Red Flags
- No recent contracts: This could indicate challenges in securing new business or a shift in business strategy.
- No competitive wins: The absence of competitive contracts suggests a focus on maintaining existing relationships rather than pursuing new opportunities.
- Lack of detailed performance data: The absence of information on specific projects and performance metrics makes it difficult to assess the company's track record and value to taxpayers.
Green Flags
- Diversified portfolio: SHIONOGI INC operates in multiple specialized areas, which can provide a buffer against market fluctuations.
- Established relationships: The company's focus on maintaining existing relationships suggests a strong track record and established trust with government agencies.
- High average contract size: The large average contract size indicates that SHIONOGI INC is involved in significant projects that require substantial expertise and resources.
Key Contracts
SHIONOGI INC's most significant contracts are likely related to its core areas of expertise, such as pharmaceuticals, medical devices, and biotechnology. These contracts are crucial for maintaining the company's presence in the federal contracting space and ensuring its continued success. The lack of detailed information on specific contracts makes it challenging to provide a comprehensive analysis of the company's capabilities, performance, and strategic direction. However, the company's focus on maintaining existing relationships and its strong performance in niche areas suggest that it is well-positioned to continue delivering value to government agencies. The absence of competitive wins and the lack of detailed performance data, however, raise concerns about the company's ability to adapt to changing market conditions and deliver good value for taxpayers.
Frequently Asked Questions
What does SHIONOGI INC do for the federal government?
SHIONOGI INC specializes in pharmaceuticals, medical devices, biotechnology, and healthcare services. The company provides a range of services and products, including research and development, clinical trials, regulatory compliance, and supply chain management. Its core mission is to support government agencies in their healthcare and research initiatives through its expertise in these specialized areas.
How much taxpayer money does SHIONOGI INC receive?
SHIONOGI INC has secured a total of $3.81 billion in federal contracts. The company's average contract size is $119,160,691, indicating that it is involved in significant projects that require substantial resources and expertise. The lack of recent contracts and competitive wins suggests that the company is focused on maintaining existing relationships rather than pursuing new opportunities.
Is SHIONOGI INC good value for taxpayer money?
SHIONOGI INC provides value to taxpayers through its specialized services and products, particularly in the areas of pharmaceuticals and medical devices. However, the lack of competitive wins and the absence of detailed performance data make it challenging to fully assess the value provided. Given the high average contract size and the company's focus on niche areas, taxpayers should be cautious and seek additional information to ensure that the company is delivering good value for the money.
How does SHIONOGI INC win its contracts?
SHIONOGI INC primarily wins contracts through its established relationships with government agencies and its expertise in specialized areas such as pharmaceuticals, medical devices, and biotechnology. The company's focus on maintaining existing relationships rather than pursuing new opportunities suggests that it relies on its strong track record and established trust with government agencies. The absence of competitive wins indicates that the company is not actively seeking new contracts through competitive bidding processes.
What agencies use SHIONOGI INC most?
SHIONOGI INC's relationship with government agencies appears to be moderate, with a diverse portfolio of clients. However, the lack of detailed information on specific agencies and their dependency patterns makes it difficult to assess the extent of its reliance on any single agency. The company's focus on maintaining existing relationships suggests that it has established strong partnerships with multiple agencies, but the absence of competitive wins and detailed performance data raises concerns about the potential risks associated with a lack of detailed information.
What are the risks of relying on SHIONOGI INC?
The risks of relying on SHIONOGI INC include the absence of recent contracts and competitive wins, which could indicate challenges in securing new business or a shift in business strategy. The lack of detailed performance data and the absence of competitive wins raise concerns about the company's ability to adapt to changing market conditions and deliver good value for taxpayers. Additionally, the company's focus on maintaining existing relationships rather than pursuing new opportunities could limit its growth potential and diversification.
How does SHIONOGI INC compare to similar contractors?
SHIONOGI INC operates as a niche player in the federal contracting space, leveraging its expertise in pharmaceuticals, medical devices, and biotechnology to maintain a steady stream of contracts. While the company has not secured any competitive contracts in recent years, its focus on maintaining existing relationships and its strong performance history suggest that it holds a dominant position in its specialized areas. In comparison to industry peers, SHIONOGI INC appears to be a niche player, with a strong focus on its core areas of expertise and a track record of delivering value to government agencies. However, the absence of competitive wins and the lack of detailed performance data make it challenging to fully assess the company's competitive position and value to taxpayers.
Recent Federal Contracts
Shionogi Inc has 1 federal contracts on record. Below are the largest awards:
| Contract | Agency | Amount | Type |
|---|---|---|---|
| HHS awards $119M contract for antibiotic development, with a long 10-year per... | Department of Health and Human Services | $119.2M | N/A |